Clinical Trials Sponsored by Beijing Sihuan Pharmaceutical Co. Ltd.

Total 4521 results

Beijing Northland Biotech. Co., Ltd.

Completed

A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers

Healthy

China
Beijing Pins Medical Co., Ltd

Unknown

Evaluate the Effectiveness and Safety of Variable Frequency Stimulation Compared With Constant Frequency Stimulation for Patients With Idiopathic Parkinson's Disease

Parkinson Disease

China
SK Medical (Beijing) Co., Ltd.

Completed

Biomarkers for Diagnosis of Lung Cancer

Lung Cancer | Lung Neoplasm

China
Beijing Pins Medical Co., Ltd

Unknown

A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB) With X-Ray Guided Technique

Refractory Overactive Bladder
Beijing Pins Medical Co., Ltd

Unknown

Evaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's Disease

Parkinson's Disease
Beijing Pins Medical Co., Ltd

Unknown

Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)

Epileptic Encephalopathy

China
Beijing Minhai Biotechnology Co., Ltd

Unknown

Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried

Haemophilus Influenzae Type b Infections

China
Beijing Biohealthcare Biotechnology Co.,Ltd

Unknown

DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment

Gastric Cancer

China
Li Peng
Betta Pharmaceuticals Co., Ltd.

Completed

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (Icotinib)

Neurofibromatosis Type 2 | Vestibular Schwannoma

China
Tongji Hospital
Fujian Cosunter Pharmaceutical Co. Ltd; Beijing Kawin Technology Share-Holding...

Completed

Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients

Hepatitis B, Chronic

China
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetics of Probucol and Cilostazol

Healthy

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects. (OPS-2071Ph1)

Healthy

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Tourette's Disorder | Chronic Motor or Vocal Tic Disorder

Korea, Republic of
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Unknown

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Oral Mucositis

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.
Shanghai Haini Pharmaceutical Co., Ltd.

Active, not recruiting

A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects

Phase 1 Study, Healthy Volunteers

China
Shouyao Holdings (Beijing) Co. LTD

Not yet recruiting

A Study to Evaluate the Mass Balance of [14C] SY-5007 in Healthy Adult Male Subjects in China

Healthy Subjects

China
Adai Technology (Beijing) Co., Ltd.

Recruiting

Digital Intervention for Depression and Anxiety in Adolescents

Depression | Anxiety

China
Biocells (Beijing) Biotech Co.,Ltd

Recruiting

BXOS110 Injection in the Treatment of Acute Ischaemic Stroke

Acute Ischemic Stroke

China
Shouyao Holdings (Beijing) Co. LTD

Not yet recruiting

A Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

Non-small Cell Lung Cancer

China
Beijing Mabworks Biotech Co., Ltd.

Recruiting

A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.

Relapsed or Refractory Multiple Myeloma

China
FutureGen Biopharmaceutical (Beijing) Co., Ltd

Recruiting

M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.

Locally Advanced Unresectable or Metastatic Gastric Cancer | Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects

Primary Immune Thrombocytopenia

China
Toll Biotech Co. Ltd. (Beijing)

Recruiting

A Study of Single and Multiple Oral Doses of TollB-001

Rheumatoid Arthritis

China
Newish Technology (Beijing) Co., Ltd.

Recruiting

NWRD06 DNA Plasmid for HCC After Radical Resection

Hepatocellular Carcinoma

China
Beijing Inno Medicine Co., Ltd.

Recruiting

YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis

Atherosclerotic Cardiovascular Disease

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

China
Shouyao Holdings (Beijing) Co. LTD

Recruiting

Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC

Non-Small Cell Lung Cancer

China
Newish Technology (Beijing) Co., Ltd.

Recruiting

Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive

HSIL of Cervix

China
Beijing Mabworks Biotech Co., Ltd.

Recruiting

A Clinical Study of MIL62 in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Beijing Inno Medicine Co., Ltd.

Recruiting

A First-in-human Study of YN001 in Healthy Volunteers

Cardiovascular Diseases

Australia
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Advanced Solid Tumors | Relapsed Or Refractory Non-Hodgkin Lymphoma

China
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

A Study to Assess YH003 in Combination With Pebolizumab and Albumin Paclitaxel Injection in Subjects With Unresectable/Metastatic Mucosal Melanoma

Mucosal Melanoma

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

ANCA-associated Vasculitis

China
FutureGen Biopharmaceutical (Beijing) Co., Ltd

Recruiting

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

Advanced Unresectable Solid Tumors

China
Beijing Mabworks Biotech Co., Ltd.

Recruiting

A Clinical Study of MIL95 in Advanced Malignancies.

Advanced Malignancies

China
Beijing Doing Biomedical Co., Ltd.

Not yet recruiting

Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL

Lymphoma | Leukemia

China
Adai Technology (Beijing) Co., Ltd.

Completed

Game-Based Digital Intervention for Relieving Depression and Anxiety Symptoms

Depression | Anxiety

China
Eucure (Beijing) Biopharma Co., Ltd

Completed

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Cancer

Australia
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa

China
Beijing Pins Medical Co., Ltd

Completed

Efficacy and Safety of DBS in Patients With Primary Dystonia

Dystonia

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

A Study of STSA-1002 in Healthy Subjects

Healthy Subject

China
Beijing Northland Biotech. Co., Ltd.

Completed

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Chemotherapy-induced Thrombocytopenia

China
Beijing Dongfang Biotech Co., Ltd.

Completed

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09

Diabetes Mellitus, Type 2

China
Beijing Northland Biotech. Co., Ltd.

Completed

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003CLI-II)

Ischemia | Peripheral Vascular Disease | Arterial Occlusive Disease | Ulcers

China
Beijing Doing Biomedical Co., Ltd.

Unknown

Safety and Efficacy of γδ T Cell Against Gastric Cancer

Gastric Cancer

China
Beijing Pins Medical Co., Ltd

Unknown

Efficacy and Safety of Spinal Cord Stimulation in Patients With Chronic Intractable Pain

Nervous System Diseases | Pain | Back Pain | Chronic Pain | Spinal Cord Stimulation

China
Beijing Doing Biomedical Co., Ltd.

Unknown

Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.

Gastric Cancer

China
Beijing Pins Medical Co., Ltd

Completed

Variable Frequency Stimulation of Subthalamic Nucleus for Freezing of Gait in Parkinson's Disease

Parkinson's Disease

China
Beijing Viroad Biotechnology Co., Ltd.

Unknown

The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device

Circulating Tumor Cells.Breast

China
Beijing Dongfang Biotech Co., Ltd.

Unknown

a Study of JY09 in Chinese Healthy Subjects

Healthy

3

Subscribe